Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | MMP10 | P09238 | 1/20 | 0.39 |
| ▸ | GCK | P35557 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 4/20 | 0.37 |
| ▸ | KAT6A | Q92794 | 5/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 3/20 | 0.35 |
| ▸ | MRGPRX1 | Q96LB2 | 1/20 | 0.35 |
| ▸ | RAF1 | P04049 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14364351 | 0.91 | CASP1 (0.40) | GCKCASP1TBXA2RMRGPRX1NPC1 | |
| SCHEMBL14364342 | 0.88 | CASP1 (0.40) | MMP3MMP10CASP1TBXA2R | |
| SCHEMBL14278008 | 0.88 | GCK (0.40) | MMP3MMP10GCKCASP1KAT6A | |
| SCHEMBL14364339 | 0.88 | TBXA2R (0.42) | MMP3MMP10CASP1TBXA2RMRGPRX1 | |
| SCHEMBL14364353 | 0.87 | MEN1 (0.38) | GCKCASP1TBXA2RMRGPRX1POLB | |
| SCHEMBL14364334 | 0.87 | CASP1 (0.44) | MMP3MMP10CASP1 | |
| SCHEMBL14364356 | 0.80 | POLB (0.43) | KAT6APOLB | |
| SCHEMBL14278015 | 0.79 | CASP1 (0.41) | GCKCASP1KAT6ATBXA2RMRGPRX1 | |
| SCHEMBL14364309 | 0.76 | CA1 (0.41) | POLB | |
| SCHEMBL14278006 | 0.75 | CASP1 (0.41) | CASP1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070265281-A1 | Organic Compounds and Their Uses | COTTENS SYLVAIN | 2007-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265281-A1 | Organic Compounds and Their Uses | OAT, OTC, AOX1 | MMP3 1168/4885MMP10 1269/4885GCK 890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.